Al-Matary Abdulrahman, Al Sulaiman Mustafa, Al-Otaiby Shahad, Qaraqei Mostafa, Al-Matary Maram
Neonatology Department, King Fahad Medical City, P.O.BOX: 59046, Riyadh 11525, Saudi Arabia.
Clinical Research Specialist, Scientific Writing, King Fahad Medical City, P.O.BOX: 59046, Riyadh 11525, Saudi Arabia.
J Infect Public Health. 2022 Jun;15(6):643-647. doi: 10.1016/j.jiph.2022.05.004. Epub 2022 May 17.
Sepsis is a life-threatening condition that requires aggressive and rapid intervention. However, data on the association between antibiotic administration timing in neonatal sepsis and neonatal outcomes is limited, particularly in the gulf area.
This study aimed to evaluate the association between the timing of antibiotic administration and the outcome of neonatal sepsis.
This retrospective comparative study was conducted through data collection from medical records of patients with neonatal sepsis. The patients were categorized into two groups based on the time interval between antibiotic prescription and drug administration: non-delayed group consisted of patients who received antibiotics within 3 h and the delayed group consisted of those who received antibiotics after 3 h.
A total of 237 neonates diagnosed with sepsis were included, of which 9.3% had necrotizing enterocolitis, 35% had bronchopulmonary dysplasia, and 6.3% had maternal chorioamnionitis. Additionally, 18.6% of the neonates' mothers were prescribed with antibiotics during labor, and 5.5% had maternal fever. Staphylococcus epidermidis was the most commonly isolated strain (24.1%). Of the total neonates, 87.3% received antibiotics within the first 3 h from the prescription. Survival rate was significantly higher and the risk of complications such as necrotizing enterocolitis, and bronchopulmonary dysplasia was significantly lower in the non-delayed group. Moreover, the length of hospital stay was significantly shorter in the non-delayed group.
Early antibiotic administration in patients with neonatal sepsis can improve the survival rate and reduce the incidence of complications.
脓毒症是一种危及生命的疾病,需要积极快速的干预。然而,关于新生儿脓毒症抗生素给药时机与新生儿结局之间关联的数据有限,尤其是在海湾地区。
本研究旨在评估抗生素给药时机与新生儿脓毒症结局之间的关联。
本回顾性对照研究通过收集新生儿脓毒症患者的病历数据进行。根据抗生素处方与给药之间的时间间隔,将患者分为两组:非延迟组由在3小时内接受抗生素治疗的患者组成,延迟组由在3小时后接受抗生素治疗的患者组成。
共纳入237例诊断为脓毒症的新生儿,其中9.3%患有坏死性小肠结肠炎,35%患有支气管肺发育不良,6.3%患有产妇绒毛膜羊膜炎。此外,18.6%的新生儿母亲在分娩期间使用了抗生素,5.5%的产妇发热。表皮葡萄球菌是最常见的分离菌株(24.1%)。在所有新生儿中,87.3%在处方后3小时内接受了抗生素治疗。非延迟组的生存率显著更高,坏死性小肠结肠炎和支气管肺发育不良等并发症的风险显著更低。此外,非延迟组的住院时间显著更短。
新生儿脓毒症患者早期使用抗生素可提高生存率并降低并发症发生率。